FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

39807911000001107: Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jul 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1844761000001116 Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1844771000001114 Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Is a Cabazitaxel 45mg/4.5ml solution for infusion vials true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient Cabazitaxel monohydrate true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cabazitaxel true Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) 1 vial Has AMP True Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start